R.D. Gelber

A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.

R.D. Gelber, Aron Goldhirsch · Journal of Clinical Oncology · 1986 · 233 citations

Surgical Oncology, Breast Oncology, Cancer Management +18

Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.

Robert C. Bast, Paolo de Fabritiis, Jeffrey M. Lipton et al. · PubMed · 1985 · 128 citations

Cell Therapy, Malignant Clonogenic Cells, Immunology +18

A Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Adjuvant Radiation Therapy and Chemotherapy for Resectable Rectal Cancer

R.D. Gelber, Aron Goldhirsch, Bernard F. Cole et al. · JNCI Journal of the National Cancer Institute · 1996 · 128 citations · Full text

BIG 1–98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer

B. J. Thurlimann, Aparna Keshaviah, H.T. Mouridsen et al. · Journal of Clinical Oncology · 2005 · 120 citations

Endocrine Oncology, Breast Oncology, Health Sciences +14

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

Aparna Keshaviah, Silvia Dellapasqua, Nicole Rotmensz et al. · Annals of Oncology · 2007 · 105 citations · Full text

Breast Cancer Recurrence, Breast Oncology, Cancer Epidemiology +10